These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 19025933

  • 1. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B, Sebagh M, Canfora ML, Antonini T, Roque-Afonso AM, Delvart V, Saliba F, Duclos-Vallee JC, Castaing D, Samuel D.
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis.
    Berenguer M, Aguilera V, Prieto M, Ortiz C, Rodríguez M, Gentili F, Risalde B, Rubin A, Cañada R, Palau A, Rayón JM.
    Liver Transpl; 2009 Jul; 15(7):738-46. PubMed ID: 19562707
    [Abstract] [Full Text] [Related]

  • 6. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
    Rao HY, Li J, Zhang LF, Chen HY, Zhu LM, Wei L, Sun Y, Wang H.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 08; 88(2):96-100. PubMed ID: 18353212
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of hepatitis C virus infection in thalassemia.
    Butensky E, Pakbaz Z, Foote D, Walters MC, Vichinsky EP, Harmatz P.
    Ann N Y Acad Sci; 2005 Jan 08; 1054():290-9. PubMed ID: 16339677
    [Abstract] [Full Text] [Related]

  • 9. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
    Rao HY, Wei L, Li J, Zhang LF, Chen HY, Zhu LM, Liu F, Sun Y, Wang H.
    Hepatogastroenterology; 2009 Jan 08; 56(90):328-34. PubMed ID: 19579592
    [Abstract] [Full Text] [Related]

  • 10. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
    Poustchi H, Negro F, Hui J, Cua IH, Brandt LR, Kench JG, George J.
    J Hepatol; 2008 Jan 08; 48(1):28-34. PubMed ID: 17977612
    [Abstract] [Full Text] [Related]

  • 11. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients.
    Kobayashi S, Takeda T, Enomoto M, Tamori A, Kawada N, Habu D, Sakaguchi H, Kuroda T, Kioka K, Kim SR, Kanno T, Ueda T, Hirano M, Fujimoto S, Jomura H, Nishiguchi S, Seki S.
    Liver Int; 2007 Mar 08; 27(2):186-91. PubMed ID: 17311612
    [Abstract] [Full Text] [Related]

  • 12. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
    Bani-Sadr F, Lapidus N, Bedossa P, De Boever CM, Perronne C, Halfon P, Pol S, Carrat F, Cacoub P, French National Agency for Research on AIDS, Viral Hepatitis-HC02-Ribavic Study Team.
    Clin Infect Dis; 2008 Mar 01; 46(5):768-74. PubMed ID: 18248298
    [Abstract] [Full Text] [Related]

  • 13. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B, Jung MC, Schirren CA, Loehe F, Thiel M, Nitschko H, Diepolder H, Ulsenheimer A, Heeg M, Zachoval R, Gruener NH.
    Eur J Gastroenterol Hepatol; 2008 Aug 01; 20(8):778-83. PubMed ID: 18617783
    [Abstract] [Full Text] [Related]

  • 14. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
    Liu CH, Kao JH.
    J Gastroenterol Hepatol; 2011 Feb 01; 26(2):228-39. PubMed ID: 21261711
    [Abstract] [Full Text] [Related]

  • 15. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
    Antúnez I, Aponte N, Fernández-Carbia A, Rodríguez-Perez F, Toro DH.
    P R Health Sci J; 2004 Jun 01; 23(2 Suppl):57-60. PubMed ID: 16929588
    [Abstract] [Full Text] [Related]

  • 16. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience.
    Burra P, Targhetta S, Pevere S, Boninsegna S, Guido M, Canova D, Brolese A, Masier A, D'Aloiso C, Germani G, Tomat S, Fagiuoli S.
    Transplant Proc; 2006 May 01; 38(4):1127-30. PubMed ID: 16757285
    [Abstract] [Full Text] [Related]

  • 17. Review article: the treatment of hepatitis C virus recurrence after liver transplantation.
    Arjal RR, Burton JR, Villamil F, Rosen HR.
    Aliment Pharmacol Ther; 2007 Jul 15; 26(2):127-40. PubMed ID: 17593060
    [Abstract] [Full Text] [Related]

  • 18. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Maylin S, Martinot-Peignoux M, Moucari R, Boyer N, Ripault MP, Cazals-Hatem D, Giuily N, Castelnau C, Cardoso AC, Asselah T, Féray C, Nicolas-Chanoine MH, Bedossa P, Marcellin P.
    Gastroenterology; 2008 Sep 15; 135(3):821-9. PubMed ID: 18593587
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An updated follow-up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy.
    Cesaro S, Bortolotti F, Petris MG, Brugiolo A, Guido M, Carli M.
    Pediatr Blood Cancer; 2010 Jul 15; 55(1):108-12. PubMed ID: 20127849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.